GWAS results from three phenotypes with significantly overlapping genetic architectures (schizophrenia, major depression, and educational attainment), seven additional loci shared with other traits are identified at equally strict significance levels. Dissecting the polygenic architecture we find both quantitative and qualitative polygenic heterogeneity across ASD subtypes, in contrast to what is typically seen in other complex disorders. These results highlight biological insights, particularly relating to neuronal function and corticogenesis and establish that GWAS performed at scale will be much more productive in the near term in ASD, just as it has been in a broad range of important psychiatric and diverse medical phenotypes.
ASD is the term for a group of pervasive neurodevelopmental disorders characterized by impaired social and communication skills along with repetitive and restrictive behavior. The clinical presentation is very heterogeneous including individuals with severe impairment and intellectual disability as well as individuals with above average IQ and high levels of academic and occupational functioning. ASD affects 1-1.5% of individuals and is highly heritable, with both common and rare variants contributing to its etiology [1] [2] [3] [4] . Common variants have been estimated to account for a major part of ASD liability 2 as has been observed for other common neuropsychiatric disorders. By contrast, de novo mutations, mostly copy number variants (CNVs) and gene disrupting point mutations, have larger individual effects, but collectively explain <5% of the overall liability [1] [2] [3] and far less of the heritability. While a number of genes have been convincingly implicated via excess statistical aggregation of de novo mutations, the largest GWAS to date (n=7387 cases scanned) -while providing compelling evidence for the bulk contribution of common variants -did not conclusively identify single variants at genome-wide significance [5] [6] [7] . This underscored that common variants, as in other complex diseases such as schizophrenia,
individually have low impact and that a substantial scale-up in sample numbers would be needed.
Here we report the first common risk variants robustly associated with ASD by more than doubling the discovery sample size compared to previous GWAS [5] [6] [7] [8] . We describe strong genetic correlations between ASDs and other complex disorders and traits, confirming shared etiology, and we show results indicating differences in the polygenic architecture across clinical sub-types of ASD. Leveraging these relationships and recently introduced computational techniques 9 , we identify additional novel ASD-associated variants that are shared with other phenotypes. Furthermore, by integrating with complementary data from Hi-C chromatin interaction analysis of fetal brains and brain transcriptome data, we explore the functional implications of our top-ranking GWAS results.
Results

GWAS
As part of the iPSYCH project (http://ipsych.au.dk) 10 , we collected and genotyped a Danish nation-wide population-based case-cohort sample including nearly all individuals born in Denmark between 1981 and 2005 and diagnosed with ASD (according to ICD-10) before 2014. We randomly selected controls from the same birth cohorts (Table S1.1.1). We have previously validated registry-based ASD diagnoses 11, 12 and demonstrated the accuracy of genotyping DNA extracted and amplified from bloodspots collected shortly after birth 13, 14 .
Genotypes were processed using Ricopili 15 , performing stringent quality control of data, removal of related individuals, exclusion of ancestry outliers based on principal component analysis, and imputation 16, 17 using the 1000 Genomes Project phase 3 reference panel. After this processing, genotypes from 13,076 cases and 22,664 controls from the iPSYCH sample were included in analysis. As is now standard in human complex trait genomics, our primary analysis is a meta-analysis of the iPSYCH ASD results with five family-based trio samples of European ancestry from the Psychiatric Genomics Consortium (PGC, 5,305 cases and 5,305 pseudo controls 18 . All PGC samples had been processed using the same Ricopili pipeline for QC, imputation and analysis as employed here.
Supporting the consistency between the study designs, the iPSYCH population-based and PGC family-based analyses showed a high degree of genetic correlation with = 0.779 (SE = 0.106; P = 1.75 x 10 -13 ), similar to the genetic correlations observed between datasets in other mental disorders 19 . Likewise, polygenicity as assessed by polygenic risk scores (PRS) 20 showed consistency across the samples supporting homogeneity of effects across samples and study designs ( Figure S4.4.4) . SNP heritability (ℎ 2 ) was estimated to be 0.118 (SE = 0.010, for population prevalence of 0.012 21 ).
The main GWAS meta-analysis totaled 18,381 ASD cases and 27,969 controls, and applied an inverse variance-weighted fixed effects model 22 . To ensure that the analysis was wellpowered and robust, we examined markers with minor allele frequency (MAF) ≥ 0.01, imputation INFO score ≥ 0.7, and supported by an effective sample size in >70% of the total.
This final meta-analysis included results for 9,112,387 autosomal markers and yielded 93
genome-wide significant markers in three separate loci ( Figure 1 ; 
2).
An overall replication of direction of effects was observed (53 of 88 (60%) of P < 1x10 -5 ; 16 of 23 (70%) at P < 1x10 -6 ; both sign tests P < 0.05) and two additional loci achieved genome-wide significance in the combined analysis (Table 1a) . More details on the identified loci can be found in Table S3 .1.3 and selected candidates are described in Box1.
Correlation with other traits and multi-trait GWAS
To investigate the extent of genetic overlap between ASD and other phenotypes we estimated the genetic correlations with a broad set of psychiatric and other medical diseases, disorders, and traits available at LD Hub 24,25 using bivariate LD score regression (Figure 2 , In order to leverage these observations for the discovery of ASD loci shared with these other traits, we selected three particularly well-powered and genetically correlated phenotypes.
These were schizophrenia (N = 79,641) 15 , major depression (N = 424,015) 29 and educational attainment (N = 328,917) 26 . We utilize the recently introduced MTAG method 9 which, briefly, generalizes the standard inverse-variance weighted meta-analysis for multiple phenotypes. In this case, MTAG takes advantage of the fact that, given an overall genetic correlation between ASD and a second trait, the effect size estimate and evidence for association to ASD can be improved by appropriate use of the association information from the second trait. The results of these three ASD-anchored MTAG scans are correlated to the primary ASD scan (and to each other) but given the exploration of three scans, we utilize a more conservative threshold of 1.67 x 10 -8 for declaring significance across these secondary scans. In addition to stronger evidence for several of the ASD hits defined above, variants in seven additional regions achieve genome-wide significance, including three loci shared with educational attainment and four shared with major depression (Table 1b, Box 1).
Gene and gene-set analysis
Next, we performed gene-based association analysis on our primary ASD meta-analysis using MAGMA 32 , testing for the joint association of all markers within a locus (across all protein-coding genes in the genome). This analysis identified 15 genes surpassing the significance threshold ( 
Dissection of the polygenic architecture
As ASD is a highly heterogeneous disorder, we explored how ℎ 2 partitioned across phenotypic sub-categories in the iPSYCH sample and estimated the genetic correlations between these groups using GCTA [40] [41] [42] . We examined cases with and without intellectual reducing to non-overlapping groups when doing pairwise comparisons (see Table S2 .3.1).
While the pairwise genetic correlations were consistently high between all sub-groups (95% CIs including 1 in all comparisons), the ℎ 2 of Asperger's syndrome (ℎ 2 = 0.097, SE = 0.001) was found to be twice the ℎ 2 of both childhood autism (ℎ 2 = 0.049, SE = 0.009, P = 0.001) and the group of other/unspecified PDD (ℎ 2 = 0.045, SE = 0.008, P = 0.001) ( To further examine the apparent polygenic heterogeneity across subtypes, we investigated how PRS trained on different phenotypes were distributed across distinct ASD subgroups.
We focused on phenotypes showing strong genetic correlation with ASD (e.g., educational attainment), but included also traits with little or no correlation to ASD (e.g., BMI) as negative controls. In this analysis, we regressed the normalized scores on ASD subgroups while including covariates for batches and principal components in a multivariate regression.
Of the eight phenotypes we evaluated, only the cognitive phenotypes showed strong heterogeneity (educational attainment 26 P = 1.8 x 10 -8 , IQ 43 P = 3.7 x 10 -9 ) ( Figure S4. 
4.8).
Interestingly, all case-control groups with or without ID showed significantly different loading for the two cognitive phenotypes: controls with ID have the lowest score followed by ASD cases with ID, and ASD cases without ID have significantly higher scores again than any other group (P = 2.6 x 10 -12 for educational attainment, P = 8.2 x 10 -12 for IQ).
With respect to the diagnostic sub-categories constructed hierarchically from ASD subtypes (Table S2. 3.1), it was again the cognitive phenotypes that showed the strongest heterogeneity across the diagnostic classes (educational attainment P = 2.6 x 10 -11 , IQ P = 3.4 x 10 -8 ), while neuroticism 27 (P = 0.0015), chronotype 44 (P = 0.011) and subjective wellbeing 27 (P = 0.029) showed weaker but nominally significant degree of heterogeneity, and SCZ, MDD and BMI were non-significant across the groups (P > 0.19) (Figure 3 ). This pattern weakened only slightly when excluding subjects with ID ( Figure S4 
Functional annotation
In order to obtain information on possible biological underpinnings of our GWAS results we conducted several analyses. First, we examined how the ASD ℎ 2 partitioned on functional genomic categories as well as on cell type-specific regulatory elements using stratified LD score regression 47 . This analysis revealed significant enrichment of heritability in conserved DNA regions and H3K4me1 histone marks 48 regulatory events occur at a distance via chromosome looping, we leveraged Hi-C data from germinal zone (GZ) and post-mitotic zones cortical plate (CP) in the developing fetal brain to identify potential target genes for these variants 49 . We performed fine mapping of 29 loci to identify the set of credible variants containing likely causal genetic risk 50 (see Methods).
Credible SNPs were significantly enriched with enhancer marks in the fetal brain ( Figure   S4 .5.1), again confirming the likely regulatory role of these SNPs during brain development.
Based on location or evidence of physical contact from Hi-C, the 380 credible SNPs (29 loci) could be assigned to 95 genes (40 protein-coding), including 39 SNPs within promoters that were assigned to 9 genes, and 16 SNPs within the protein coding sequence of 8 genes (Table S3. Interestingly, both common and rare variation in ASD preferentially affects genes expressed during corticogenesis 33 , highlighting a potential spatiotemporal convergence of genetic risk on this specific developmental epoch, despite the disorder's profound genetic heterogeneity.
Discussion
The high heritability of ASD has been recognized for decades and remains among the highest for any complex disease despite many clinical diagnostic changes over the past 30-40 years resulting in a broader phenotype that characterizes more than 1% of the population.
While early GWAS permitted estimates that common polygenic variation should explain a substantial fraction of the heritability of ASD, individually significant loci remained elusive.
This was suspected to be due to limited sample size since studies of schizophrenia -with similar prevalence, heritability and reduced fitness -and major depression achieved striking results only when sample sizes five to ten times larger than available in ASD were employed. This study has finally borne out that expectation with definitively demonstrated significant "hits".
Here we report the first common risk variants robustly associated with ASD by using unique
Danish resources in conjunction with results of the earlier PGC data -more than tripling the previous largest discovery sample. Of these, five loci were defined in ASD alone, and seven additional suggested at a stricter threshold utilizing GWAS results from three correlated phenotypes (schizophrenia, depression and educational attainment) and a recently introduced analytic approach, MTAG. Both genome-wide LD score regression analysis and the fact that even among the loci defined in ASD alone there was additional evidence in these other trait scans indicate that the polygenic architecture of ASD is significantly shared with risk to adult psychiatric illness and higher educational attainment and intelligence. It should be noted that the MTAG analyses were carried out as three pairwise analyses. This way we avoid the complex interactions that could arise if we ran three or four correlated phenotypes at a time 9 . Indeed, what we get, despite the secondary summary statistics coming from large, high-powered studies, are relatively modest weights to the contributions from these statistics, because the genetic correlations are modest. The largest weight was 0.27 for schizophrenia, followed by 0.24 for major depression, and 0.11 for educational attainment. Thus all loci identified by MTAG have substantial contributions from ASD alone (Table 1a , b) and will most likely also be identified in future ASD-only GWAS with increasing sample sizes.
In most GWAS studies there has been little evidence of heterogeneity of association across phenotypic subgroups. In this study, however, we see strong heterogeneity of genetic overlap with other traits when our ASD samples are broken into distinct subsets. In particular, the excess of alleles associated with higher intelligence and educational attainment was only observed in the higher functioning categories (particularly Asperger's syndrome and individuals without comorbid ID) -and not in the other/unspecified PDD and ID categories. This is reminiscent, and logically inverted, from the much greater role of spontaneous mutations in these latter categories, particularly in genes known to have an even larger impact in cohorts ascertained for ID/DD 51 . Interestingly, other/unspecified PDD and atypical autism also have a significantly higher PRS for neuroticism than childhood autism and Asperger's. These different enrichment profiles observed provide evidence for a heterogeneous and qualitatively different genetic architecture between sub-types of ASD, which should inform future studies aiming at identifying etiologies and disease mechanisms in ASD.
The strong differences in estimated SNP heritability between ASD cases with and without ID, and highest in Asperger's provide genetic evidence of longstanding observations. In particular, this aligns well with the observation that de novo variants are more frequently observed in ASD cases with ID compared to cases without comorbid ID, that IQ correlates positively with family history of psychiatric disorders 52 and that severe ID (encompassing many syndromes that confer high risk to ASD) show far less heritability than is observed for mild ID 53 , intelligence in general 54 and ASDs. Thus it is perhaps unsurprising that our data suggests that the contribution of common variants may be more prominent in highfunctioning ASD cases such as Asperger's syndrome.
We further explored the functional implications of these results with complementary functional genomics data including Hi-C analyses of fetal brains and brain transcriptome data. Analyses at genome-wide scale (partitioned ℎ 2 ( Figures S4.3.2-4 ) and brain transcriptome enrichment (Figure 5e-g) ) as well as at single loci (Figure 5a-d, Box 1) highlighted the involvement of processes relating to brain development and neuronal function. Notably, a number of genes located in the identified loci have previously been linked to ASD risk in studies of de novo and rare variants (Box 1, In summary, we have established a first compelling set of common variant associations in ASD and have begun laying the groundwork through which the biology of ASD and related phenotypes will inevitably be better articulated.
Methods
Subjects iPSYCH sample
The iPSYCH ASD sample is a part of a population based case-cohort sample extracted from a baseline cohort 10 As controls we selected a random sample from the set of eligible children excluding those with an ASD diagnosis by 2013.
The samples were linked using the unique personal identification number to the Danish Newborn Screening Biobank (DNSB) at Statens Serum Institute (SSI), where DNA was extracted from Guthrie cards and whole genome amplified in triplicates as described previously 13, 57 analysis pairs of subjects were identified with � > 0.2 and one subject of each such pair was excluded at random (with a preference for keeping cases). PCA was carried out using smartPCA 75, 76 . In iPSYCH a subsample of European ancestry was selected as an ellipsoid in the space of PC1-3 centred and scaled using the mean and 8 standard deviation of the subsample whose parents and grandparents were all known to have been born in Denmark (n=31500). In the PGC sample the CEU subset was chosen using a Euclidian distance measure weighted by the variance explain for each of the first 3 PCs. Individuals more distant than 10 standard deviations from the combined CEU and TSI HapMap reference populations were excluded. We conducted a secondary PCA to provide covariates for the association analyses. Numbers of subjects in the data generation flow for the iPSYCH sample are found in the descriptive table Table S1 .1.1.
Association analyses were done by applying PLINK 1.9 to the imputed dosage data (the sum of imputation probabilities P(A1A2) + 2P(A1A1)). In iPSYCH we included the first four principal components (PCs) as covariates as well as any PC beyond that, which were significantly associated with ASD in the sample, while the case-pseudo-controls from the PGC trios required no PC covariates. Combined results for iPSYCH and for iPSYCH with the PGC was achieved by meta-analysing batch-wise and study-wise results using METAL 77 (July 2010 version) employing an inverse variance weighted fixed effect model 22 . On chromosome X males and females were analyzed separately and then meta-analyzed together. Subsequently we applied a quality filter allowing only markers with an imputation info score ≥ 0.7, maf ≥ 0.01 and an effective sample size (see supplementary info) of at least 70% of the study maximum. The degree to which the deviation in the test statistics can be ascribed to cryptic relatedness and population stratification rather than to polygenicity was measured from the intercept in LD score regression 23 (LDSC) as the ratio of (intercept-1) and (mean(χ 2 )-1). For subsamples too small for LDSC, the GREML approach of GCTA [40] [41] [42] was used. On best guess genotypes (genotype probability > 0.8, missing rate < 0.01 and MAF > 0.05) with
INDELs removed, a genetic relatedness matrix (GRM) was fitted for the association sample In addition to this, we conducted an analysis based on annotation derived from data on H3K4Me1 imputed gapped peaks data from the Roadmap Epigenomics Mapping Consortium 80, 81 ; more specifically information excluding the broad MHC-region (chr6:25-35MB).
Genetic correlation
For the main samples, SNP correlations, , were estimated using LDSC 23 and for the analysis of ASD subtypes and subgroups where the sample size were generally small, we used GCTA 42 . In both cases, we followed the same procedures as explained above. For all but a few phenotypes, LDSC estimates of correlation were achieved by uploaded to LD hub 25 for comparison to all together 234 phenotypes.
Polygenic risk scores
For the polygenic risk scores (PRS) we clumped the summary stats applying standard Ricopili parameters (see supplementary methods for details). To avoid potential strand conflicts we excluded all ambiguous markers for summary statistics not generated by Ricopili using the same imputation reference. PRS were generated at the default p-value thresholds (5e-8, 1e-6, 1e-4, 0.001, 0.01, 0.05, 0.1, 0.2, 0.5 and 1) as a weighted sum of the allele dosages. Summing over the markers abiding by the p-value threshold in the training set and weighing by the additive scale effect measure of the marker (log(OR) or β) as estimated in the training set. Scores were normalized prior to analysis.
We evaluated the predictive power using Nagelkerke's 2 and plots of odds ratios and confidence intervals over score deciles. Both 2 and odds ratios were estimated in regression analyses including the relevant PCs and indicator variable for genotyping waves.
Lacking a large ASD sample outside of iPSYCH and PGC, we trained a set of PRS for ASD internally in the following way. We divided the sample in five subsamples of roughly equal size respecting the division into batches. We then ran five GWAS leaving out each group in turn from the training set and meta-analyzed these with the PGC results. This produced a set of PRS for each of the five subsamples trained on their complement. Prior to analyses, each score was normalized on the group where it was defined. We evaluated the predictive power in each group and on the whole sample combined.
To exploit the genetic overlap with other phenotypes to improve prediction, we created a 
Hi-C analysis
The Hi-C data was generated from two major cortical laminae: the germinal zone (GZ), containing primarily mitotically active neural progenitors, and the cortical and subcortical plate (CP), consisting primarily of post-mitotic neurons 49 . We first derived a set of credible SNPs (putative causal SNPs) from the identified top ranking 29 loci using CAVIAR 50 . To test whether credible SNPs are enriched in active marks in the fetal brain 81 , we employed GREAT as previously described 49, 82 . 
Summary statistics
The summary statistics are available for download the iPSYCH download page http://ipsych.au.dk/downloads/ and at the PGC download site:
https://www.med.unc.edu/pgc/results-and-downloads.
Box1. Selected loci and candidates (ordered by chromosome).
Gene Locus* and supporting evidence Gene function NEGR1 Chr1:72,729,142
Shared ASD-MDD locus
Locus also significant in depression 29, 78 , obesity and BMI [84] [85] [86] [87] [88] NEGR1 is the only protein-coding gene in the locus NEGR1 is supported by brain Hi-C and eQTL analyses 29 NEGR1 (neuronal growth regulator 1) is an adhesion molecule modulating synapse formation in hippocampal neurons 89, 90 and neurite outgrowth 91, 92 . It is member of the IgLON protein family implicated in synaptic plasticity and axon extension [93] [94] [95] . Predominantly expressed (and developmentally upregulated) in hippocampus and cortex 96 and also hypothalamus 97 .
PTBP2
Chr1:96,561,801
ASD locus
Locus also significant in BMI 84, 86, 88 and weight 84 . In schizophrenia the locus show p-value of 6.5x10 -6 15 PTBP2 is the nearest protein-coding gene, approx. 625kb from index SNP.
De novo and rare variants in PTBP2 have been reported in ASD cases 1, 3, 98 .
PTBP2 is supported by Hi-C results in this study (Fig. 5d) PTBP2 is also known as nPTB (neuronal PTB) or brPTB (brain PTB) and is a splicing regulator. PTBP1 and its paralog PTBP2 bind to intronic polypyrimidine tracts in pre-mRNAs and target large sets of exons to coordinate alternative splicing programs during development 99 . Several switches in the expression of PTBP1 and PTBP2 regulate alternative splicing during neurogenesis and neuronal differentiation [100] [101] [102] [103] .
CADPS
Chr3:62,481,063
Shared ASD-Educational attainment locus
Locus also significant in study of cognitive decline rate 104 CADPS is supported by Hi-C results in this study (Fig. 5a ).
CADPS encodes a calcium-binding protein involved in exocytosis of neurotransmitters and neuropeptides. In line with CAPDS mRNA being mainly expressed in brain and pituitary (gtexportal), immunoreactive CAPS-1 is localized in neural and various endocrine tissues 105 . In hippocampal synapses, CADPS regulates the pool of readily releasable vesicles at pre-synaptic terminals 106, 107 
KCNN2
Chr5: 113,801,423
ASD locus (gene-wise analysis)
Locus also significant in educational attainment 26, 108 .
KCNN2 synaptic levels are regulated by the E3 ubiquitin ligase UBE3A 109 , of which overexpression has been linked to ASD risk 109, 110 .
KCNN2 is a voltage-independent Ca
2+ -activated K + channel that responds to changes in intracellular calcium concentration and couples calcium metabolism to potassium flux and membrane excitability. In CNS neurons, activation of KCNN2 modulates neuronal excitability by causing membrane hyperpolarization 111 . Hippocampal KCNN2 has roles in the formation of new memory 112 , encoding and consolidation of contextual fear 113 , and in drug-induced plasticity 114 .
KMT2E
Chr7 . Evidence suggest that recognition of the histone H3K4me3 mark by the KMT2E PHD finger can facilitate the recruitment of KMT2E to transcription-active chromatin regions 119, 120 . KMT2E has been implicated in chromatin regulation, control of cell cycle progression, and maintaining genomic stability 121 .
MACROD2
Chr20: 14836243 ASD locus Locus found significant in previous ASD GWAS 61 but not supported in larger study 122 MACROD2 is the only protein-coding gene in the locus MACROD2 is a nuclear enzyme that binds to mono-ADP-ribosylated (MARylated) proteins and functions as an eraser of mono-ADP-ribosylation 123 . Intracellular MARylated histones and GSK3β are substrates of MACROD2, and the removal of MAR from GSK3β is responsible for reactivating of its kinase activity 123 . This gene is expressed in lung and multiple regions of the brain. Low or no expression across most other tissue (https://www.gtexportal. org).
*position of index SNP is listed. Table 1 . Genome-wide significant loci. Independent loci (r 2 < 0.1, distance > 400kb) with index variant (Index var), chromosome (CHR), chromosomal position (BP), alleles (A1/A2), allele frequency of A1 (FRQ), estimate of effect (β) with respect to A1, standard error of β (SE), and the association p-value of the index variant (P). The "Analysis" column shows the analysis that generated the particular result. The column "Support from other scans" lists the analyses that also support the locus. For the ASD scan results, this shows the genome wide significant results in the locus from the other scans, and for results from any other analysis, it shows the result from the ASD scan. An * indicate different lead SNP. The column "Nearest genes" lists nearest genes from within 50kb of the r 2 ≥0.6 LD friends of the index variant (intergenic variants marked with a dash). a. Loci from the ASD scan and the combined analysis with the follow-up sample. Column "Analysis" indicates which results stem from the original scan and which comes from the combined. b. Loci from the three MTAG analyses with schizophrenia (SCZ) 15 , educational attainment (Edu) 26 and major depression (MD) 29 -loci not already represented in section a. analyses: IQ 43 , educational attainment 26 , college 124 , self-reported tiredness 125 , neuroticism 27 , subjective well-being 27 , schizophrenia 15 , major depression 29 , depressive symptoms 27 , ADHD 30 , and chronotype 44 . See Table S3 (schizophrenia 15 , major depression 29 , educational attainment 26 , human intelligence 43 , subjective well-being 27 , chronotype 44 , neuroticism 27 and BMI 88 . The bars show coefficients from multivariate regression of the 8 normalized scores on the distinct ASD sub-types (adjusting for batches and PCs). The subtypes are the hierarchically defined subtypes for childhood autism (hCHA), atypical autism (hATA), Asperger's (hAsp), and the lumped pervasive disorders developmental group (hPDM). Beware that the orientation of the scores for subjective well-being, chronotype and BMI have been switched to improve graphical presentation. The corresponding plot where subjects with ID have been excluded can be seen in Figure S4 .4.9, and with ID as a subtype in Figure S4 .4.8.
Applying the same procedure to the internally trained ASD score did not display systematic heterogeneity (p=0.068) except as expected for the ID groups (p=0.00027) ( Figure S4.4.10) . , subjective well-being 27 , schizophrenia 15 , educational attainment 26 , and chronotype 44=44 . In all instances the P-value threshold for the score used is the one with the highest Nagelkerke's R 2 . Figures S4.4.5 and S4.4.7 show the stability across leave-one out groups that was used to create these combined results. 
